GlassScriptPhysician profile
James B Day
NPI 1346223880
$1,817.42
in general payments reported to CMS, 2019-2025
10 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.89 · 2022: $250 · 2023: $112 · 2024: $425 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.53 |
| Travel and Lodging | $430.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,292.81 | 2024-2025 | Pangea, Hoffmann, T2 Alpha |
| Smith+Nephew, INC. | $261.57 | 2022-2023 | Evos |
| Integra Lifesciences Corporation | $65.81 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| My01 INC. | $50.73 | 2023-2024 | My01 Continuous Compartmental Pressure Monitor |
| Orthofix Medical, INC. | $45.91 | 2025 | Physio-Stim |
| Zimvie INC. | $26.75 | 2023 | |
| Myriad Genetic Laboratories, INC. | $23.89 | 2024 | Mychoice Cdx |
| Ebi, LLC | $17.68 | 2025 | |
| Bioventus LLC | $16.38 | 2024 | Durolane |
| Edwards Lifesciences Corporation | $15.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.